JNNP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roberts, R. C.
Right arrow Articles by Butchart, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roberts, R. C.
Right arrow Articles by Butchart, P.

Journal of Neurology, Neurosurgery, and Psychiatry, 1994, Vol 57, 1488-1491


PAPERS

Presynaptic inhibition of soleus Ia afferent terminals in Parkinson's disease

RC Roberts, NJ Part, R Farquhar and P Butchart
University of Dundee, UK.

The possible role of changes in presynaptic inhibition of muscle spindle primary afferent terminals in Parkinson's disease was investigated. The pathway from tibialis anterior Ia afferents to soleus Ia terminals was assessed in 20 patients with Parkinson's disease and in 17 age matched controls, both at rest and during maintenance of tonic plantar flexing torques about the ankle. At all torques less presynaptic inhibition was present in the patients with Parkinson's disease than in the controls. The difference was significant at rest (p < 0.03) and at 2 Nm (p < 0.05) but not at 5 Nm and 7 Nm torque. The amount of presynaptic inhibition did not change with torque in either group. The observed alteration in presynaptic inhibition in Parkinson's disease is likely to make only a small contribution to the rigidity and impaired movement control.


© 1994 by Journal of Neurology, Neurosurgery, and Psychiatry



This article has been cited by other articles:


Home page
BrainHome page
M. Simonetta Moreau, S. Meunier, M. Vidailhet, S. Pol, M. Galitzky, and O. Rascol
Transmission of group II heteronymous pathways is enhanced in rigid lower limb of de novo patients with Parkinson's disease
Brain, September 1, 2002; 125(9): 2125 - 2133.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 1994 by the BMJ Publishing Group Ltd.